MEDIA CENTRE    |    PRINT    |     FRANÇAIS
   

Welcome to the Lady Davis Institute
 
The Lady Davis Institute (LDI) is the research arm of Montreal's Jewish General Hospital, a teaching hospital of McGill University.
 
Founded in 1969, the LDI is one of Canada's leading health research institutes. Important discoveries which have contributed to the health and well-being of patients in Quebec, Canada, and around the world, have been made by LDI researchers in the areas of HIV/AIDS, aging, cancer, vascular disease, epidemiology, and psychosocial science. There are currently more than 117 full-time researchers at the LDI, of whom 70 are primarily lab-based, 21 investigate psychosocial aspects of disease, 26 are in epidemiology. In addition, there are 124 associate investigators. 
 
 
 
 
 
                         
 
News from the LDI
 
07/04/2016
Promising antiviral target in search for an HIV cure shows surprising resilience
Research conducted at the Lady Davis Institute at the Jewish General Hospital revealed that even a tiny mutation can allow the HIV virus to become resistant to therapies using the CRISPR/Cas9 gene‐editing platform.

 more...

31/03/2016
New study confirms link between diabetes drug and increased risk of bladder cancer
A study conducted at the Lady Davis Institute at the Jewish General Hospital revealed that pioglitazone is associated with a risk of bladder cancer that increases with duration of use and dosage.

 more...



Copyright © 2010 Lady Davis Institute/Jewish General Hospital.
Created by Blue Lemon Media Inc.
Sitemap | Disclaimer